Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 781-792 of 1,740
Behavioral study icon
Not recruitingISRCTN10990143

Thin Bizzy: a multimodal lifestyle intervention for children with attention deficit hyperactivity disorder and overweight

This study is looking at a support or therapy approach for people with Attention deficit hyperactivity disorder and overweight/obesity or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 10 Years to 16 Years
Countries
Netherlands
Sponsor
Maasstad Hospital Rotterdam (Maasstadziekenhuis Rotterdam) (Netherlands)
Condition
ADHD
Other study type icon
Not recruitingISRCTN12110752

Validating an EEG-based test for ADHD: a case-control study on brain connectivity during executive task

This observational study is following people with Attention deficit/hyperactivity disorder or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Spain
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 7 Years to 12 Years
Countries
Spain
Sponsor
Bitsphi Diagnosis
Condition
ADHD
Drug study icon
CompletedEUCTR 2006-001471-37

A Randomized, Double-Blind Comparison of Atomoxetine versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.
Countries
Germany
Sponsor
Lilly Deutschland GmbH, Teichweg 3, 35396 Gießen
Condition
ADHD
Drug study icon
CompletedEUCTR 2005-005701-32

An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without comorbid conditions

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Italy
Sponsor
ELI LILLY
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2013-003888-59

ADHD: Medication or Meditation?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
University of Amsterdam
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2013-004776-35

Cross-sectional study of 24-hour ambulatory blood pressure measurements and left ventricular mass using echocardiograms in late adolescents and adults with ADHD (ADDUCE protocol WP8 (cardiovascular))

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
United Kingdom
Sponsor
Radboud University Medical Centre Nijmegen
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2016-002474-13

Medication Optimization for ADHD: MOVA study Implementation and evaluation of double-blind placebo-controlled titration in clinical practice

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Innovatiefonds Zorgverzekeraars
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2022-003237-19

The difference in pharmacodynamic and pharmacokinetic profiles between Tentin and generic dexamphetamine in adults with attention deficit hyperactivity disorder, a double-blinded randomized crossov...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Amsterdam UMC
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2012-000492-17

The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children with ADHD: A Randomised Placebo Controlled Trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.